Osaic Holdings
SKYE icon

Osaic Holdings’s Skye Bioscience SKYE Stock Holding History

Osaic Holdings’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$413 Hold
75
– – ﹤0.01% 7686
2026
Q1 		$364 Buy
+75
New +$489 ﹤0.01% 7489
2025
Q4 		– Sell
-2
Closed -$23 – 7817
2025
Q3 		$63 Sell
2
-20
-91% -$604 ﹤0.01% 7776
2025
Q2 		$327 Buy
22
+20
+1,000% +$331 ﹤0.01% 7436
2025
Q1 		$25 Hold
2
– – ﹤0.01% 7337
2024
Q4 		$45 Hold
2
– – ﹤0.01% 7301
2024
Q3 		$62 Buy
+2
New +$90 ﹤0.01% 7285

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Osaic Holdings's SKYE Position: Q2 2026 in Review

Osaic Holdings held its Skye Bioscience (SKYE) position steady in Q2 2026 at 75 shares worth $413. The position accounts for ﹤0.01% of the portfolio, ranked #7686.

Osaic Holdings first reported a position in SKYE in Q3 2024 and has held it in 7 quarters since. 33 funds tracked by Wall St. Rank hold SKYE as of Q2 2026.

  • Osaic Holdings held 75 shares of Skye Bioscience worth $413 as of Q2 2026.
  • Osaic Holdings left its Skye Bioscience share count unchanged in Q2 2026.
  • Skye Bioscience made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7686 holding.
  • Osaic Holdings first reported a position in Skye Bioscience in Q3 2024 and has held it in 7 quarters since.
  • 33 funds tracked by Wall St. Rank held Skye Bioscience as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.